9:00 - 9:45

Welcome and Introductions

Rosa Alves
Assistant Dean for Global Compliance, Seton Hall Law School (New Jersey)
Learn more about Rosa Alves >>

Kathleen M. Boozang
Dean and Professor of Law, Seton Hall Law School (New Jersey)
Learn more about Dean Boozang >>

09:45 - 10:40

Aligning the “Why” and “How” of Compliance

1. What is Corruption?
2. What is a Conflict of Interest?
3. Business Ethics
4. How is Compliance Best Achieved?
5. Values vs. Rules

Kathleen M. Boozang
Dean and Professor of Law, Seton Hall Law School (New Jersey)
Learn more about Dean Boozang >>

10:40 - 11:00

BREAK

11:00 - 11:45

FCPA Enforcement -- Questions for the DOJ

Sonali Patel
Assistant Chief, Foreign Corrupt Practices Unit, Fraud Section, U.S. Department of Justice (NY)
Learn more about Sonali Patel >>

Kathleen M. Boozang
Dean and Professor of Law, Seton Hall Law School (New Jersey)
Learn more about Dean Boozang >>

11:50 - 13:20

Global Anti-Corruption Enforcement

1. Global Anti-Corruption Treaties and Standards (OECD, UNCAC, ISO37001)
2. Overview of U.S. Foreign Corrupt Practices Act (FCPA) and UK Bribery Act
3. Asia-Pacific Anti-Corruption Laws
4. Compliance Programs
5. Life Sciences & Health Care Industry Pitfalls

Wilson Ang
Partner, Norton Rose Fulbright (Singapore)
Learn more about Wilson Ang >>

Orlando Vidal
Partner, Norton Rose Fulbright (Dubai)
Learn more about Orlando Vidal >>

 

13:20 - 14:20

LUNCH BREAK

14:20 - 15:30

Being the Focus of a Government Investigation

1. Risk to and Rights of Employees
2. The Issue of Legal Privilege
3. How to Respond to Inquiries
4. Business Continuity Plans

Yuet Ming Tham
Partner, Sidley Austin LLP (Hong Kong/Singapore)
Learn more about Yuet Ming Tham >>

Shu Min Ho
Registered Foreign Lawyer, Sidley Austin LLP
Learn more about Shu Min Ho >>

Sam Johnson
Senior Managing Associate, Sidley Austin LLP (Singapore)
Learn more about Sam Johnson >>

15:30 - 15:45

BREAK

15:45 - 17:15

Data Analytics: Enhance Your Investigation, Auditing, and Monitoring Activities

Lem Chin Kok
Partner, Head of Risk Consulting, Head of Forensic, Asia Pacific, KPMG LLP (Singapore)
Learn more about Lem Chin Kok>>

09:00 - 10:15

Anti-Corruption Settlements

1. What Went Wrong: Operationalizing Lessons Learned from Recent Enforcement Actions

Eric Carlson
Partner, Covington & Burling LLP (Shanghai)
Learn more about Eric Carlson >>

Ping An
Special Counsel, Covington & Burling LLP (Shanghai)
Learn more about Ping An >>

10:15 - 10:30

BREAK

10:30 - 11:35

China Healthcare Compliance Update

Eric Carlson
Partner, Covington & Burling LLP (Shanghai)
Learn more about Eric Carlson >>

Ping An
Special Counsel, Covington & Burling LLP (Shanghai)
Learn more about Ping An >>

11:40 - 12:45

Competition Law in Pharmaceutical & Medical Device Sectors with Korea Focus

Myung Soon Chung
Foreign Attorney, Kim & Chang (Seoul)
Learn more about Myung Soon Chung>>

Yong Hoon Cho
Attorney, Kim & Chang (Seoul)
Learn more about Yong Hoon Cho>>

12:45 - 13:45

LUNCH BREAK

13:45 - 15:15

Pharma & Device Industry Codes: How Key Interactions are Regulated Under IFPMA, APACMed, and Korean Codes

PANEL DISCUSSION:

1. Pharma & Device Industry Codes
2. Korean Transparency Requirements
3. Asia-Pacific Transparency, Trends & Challenges in Healthcare & Life Sciences Sector

Diva Duong
Global Compliance Solutions Partner, IQVIA (Paris)
Learn more about Diva Duong >>

Lucas Nicolet-Serra
Counsel, K&L Gates (Singapore)
Learn more about Lucas Nicolet-Serra >>

Eric Choi
Foreign Attorney, Kim & Chang
Learn more about Eric Choi>>

Hyok-Chan Kwon
Attorney, Kim & Chang
Learn more about Hyok-Chan Kwon>>

15:15 - 15:30

BREAK

15:30 - 16:30

ASIA Transparency Trends & Challenges

Lucas Nicolet-Serra
Counsel, K&L Gates (Singapore)
Learn more about Lucas Nicolet-Serra >>

Diva Duong
Global Compliance Solutions Partner, IQVIA (Paris)
Learn more about Diva Duong >>

16:35 - 17:45

Interactive Session

1. Compliance Officers Panel Discussion
2. Audience Q&A

Maija Burtmanis
General Counsel & Chief Compliance Officer, Zuellig Pharma (Singapore)
Learn more about Maija Burtmanis >>

Stephanie Chew
Partner, Advisory Risk, KPMG (Shanghai)
Learn more about Stephanie Chew >>

Ronald Goon
Ethics & Business Integrity Head, Sanofi (Shanghai)
Learn more about Ronald Goon >>

Paul Sumilas
VP, Compliance Officer, Sen. Legal Counsel, Zimmer Biomet (Singapore)
Learn more about Paul Sumilas >>

MODERATOR: Jacob Elberg
Professor of Law & Co-Director, Center for Health & Pharmaceutical Law, Seton Hall Law School (New Jersey)
Learn more about Jacob Elberg >>

09:00 - 09:40

Compliance Issues in Clinical Studies

Carl Coleman
Professor of Law, Seton Hall Law School (New Jersey)
Learn more about Carl Coleman >>

09:45 - 10:55

Assessing Third-Party Risk

1. Key Risk Areas
2. Due Diligence Best Practices
3. Lessons Learned

Christopher Pelham
Partner, Norton Rose Fulbright (Los Angeles, CA)
Learn more about Christopher Pelham >>

10:45 - 11:00

BREAK

11:00 - 12:10

Health Care in India: Regulatory Compliance— Prevention is Better Than a Cure

Dr. Milind Antani
Nishith Desai Associates (Mumbai)
Learn more about Dr. Milind Antani >>

Darren Punnen
Nishith Desai Associates (Mumbai)
Learn more about Darren Punnen >>

12:10 - 13:10

LUNCH BREAK

13:10 - 14:40

Key Requirements for an Essential Service Logistics Provider in a Pandemic

Maija Burtmanis
General Counsel & Chief Compliance Officer Zuellig Pharma (Singapore)
Learn more about Maija Burtmanis >>

14:45 - 16:45

Interactive Session - Part 1 (Group Work)

Case Study Workshop Prep

1. Assign Teams
2. Provide Case Study
3. Teamwork: Evaluate proposed activities, assess business & legal risk, develop recommendations

16:50 - 17:30

VIRTUAL NETWORKING RECEPTION (for all program faculty & attendees)

09:00 - 09:45

A Journey to the Dark Side of International Business: Real-World Risk and Real-World Lessons—Ask Richard

Richard Bistrong
CEO, Front-Line Anti-Bribery LLC (Connecticut)
Learn more about Richard Bistrong >>

09:50 - 10:50

Data Protection Risks as Related to Anti-Corruption Compliance, Mergers & Acquisitions, and Internal Investigations

Ken Chia
Principal, Baker & McKenzie, Wong & Leow LLC (Singapore)
Learn more about Ken Chia >>

10:50 - 11:05

BREAK

11:05 - 11:50

How to Build an Effective Ethics & Compliance Program & Team!

Stephanie Chew
Partner, Advisory Risk, KPMG (Shanghai)
Learn more about Stephanie Chew >>

11:55 - 12:35

How to Be Recognized as a Trusted Compliance Professional

Young Sang Kwon
HCC Sector Lead, Johnson & Johnson, Asia Pacific (Singapore)
Learn more about Young Sang Kwon >>

12:35 - 13:35

BREAK

13:35 - 14:00

Interactive Session - Part 2 (Group Work)

1. Teamwork: Evaluate proposed activities, assess business & legal risk, develop recommendations (continuation/finalization of Part 1)

14:05 - 16:00

Interactive Session - Part 3

1. Team Presentations & Classroom Discussion

Ronald Goon
Ethics & Business Integrity Head, Sanofi (Shanghai)
Learn more about Ronald Goon >>

16:00 - 16:30

Closing Remarks & Awarding of Program Certificates